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Abstract
Background: The AMS is an internationally used health-related quality of life (HRQoL) scale. The
aim of this paper is to provide evidence that the French AMS scale measures HRQoL are as valid
as other language versions. We also intend to show whether the application of AMS is really limited
to aging males only or not. More generally, we like to demonstrate that the AMS scale is a relevant,
validated, sensitive instrument to measure HRQoL and change of symptoms in France.
Methods: We performed a representative survey in France to get data AMS scale data. The French
data were compared with existing data from other European countries. Only community-based
data were used for this comparison.
Results and Discussion: Reliability (here consistency, Cronbach' s alpha) was found to be good
and almost identical with other countries. Validity: the internal structure of the AMS (factorial
analysis) was sufficiently comparable with the comparison group of other countries in Europe to
conclude that the scale really measures the same phenomenon. The sub-scores and total score
correlations (Pearson) were high (r = 0.8–0.9) but only somewhat lower among the sub-scales (r
= 0.5–0.7). This suggests that the domains are correlated.
The comparison of the French AMS with the generic quality-of-life scale SF-12 showed a good
correlation (Pearson r = 0.48 – 0.51) as reported from other countries. We observed also a good
correlation between the AMS scale and the depression scale HAD (Pearson r = 0.62).
The analysis of the AMS structure across age groups showed sufficient similarity to suggest that the
AMS is also useful for younger age groups.
Conclusion: The French AMS scale is a standardized HRQoL scale with good psychometric
characteristics (reliability, validity) as shown for other international versions. We suggest that the
AMS scale could be also used in age groups under 40 years to measure and compare HRQoL in
males. Since the application of the AMS in younger age was not investigated before, confirmation
in future studies is needed.
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Background
The Aging Males' Symptoms (AMS) scale was originally
developed as symptoms profile scale in Germany to eval-
uate health-related quality of life (HRQoL) [1]. It is a self-
administered scale to assess symptoms of aging, to com-
pare the severity of complaints, and to measure therapeu-
tic interventions [1-3].
The AMS scale is an internationally used scale. Currently,
translations into 17 languages are available following
methodological recommendations for linguistic and cul-
tural adaptation. These versions are available in a pub-
lished form [2,4,5] and can be downloaded from the
Internet http://www.aging-males-symptoms-scale.info.
Norm values of the standardized AMS scores (total score
and three domain scores) however were only published
for Germany until now. In addition, little is published yet
about the comparability of the scale across countries,
except one recent paper that provided promising impres-
sions, based however on small numbers in most of the
countries [6]. It is important to analyze if the scale meas-
ures similarly in different countries or whether one could
pool results of clinical studies across countries.
The aim of this paper is to provide evidence that the
French AMS scale measures similarly (similar reliability
and validity) compared with other language versions. We
also intend to show whether the application of AMS is
really limited to aging males only or not. More generally,
we would like to demonstrate that the AMS scale is a rele-
vant, validated, sensitive instrument to measure HRQoL
and change of symptoms in France.
Methods
The French data are based on representative national sam-
ple of French males aged 15 and more years: 963 males
underwent a computer-assisted telephone interview that
included the French AMS scale [7]. This approach is in full
agreement with national ethical regulations and data pri-
vacy rules. AMS scores were available for 903 men. The
sample was constructed using quotas method by stratifica-
tion on sex, age, householder's profession, geographic
region and population density.
We compared the French data with existing data from
other European AMS data built the comparator for this
methods paper. Results of this database were published
recently [6] as methodological paper of the AMS scale and
kindly provided by L.A.J. Heinemann for looking at possi-
ble similarities or differences of the French AMS scale.
Only community-based European data were used for this
comparison: men aged 40 years and more. The bulk of the
data came from Germany (96%), UK (2%), and only very
small samples (n < 40) from Spain, Portugal, Italy, and
Sweden [6]. These samples were combined to build the
dataset called "Europe, others" in the following text and
tables. The important difference with the French database
is the absence of males under 40 years in the "Europe, oth-
ers" data.
Using these two databases, we were able to review the
most fundamental psychometric characteristics of the
French AMS, i.e., particularly reliability and some aspects
of validity.
It is the first quality requirement for a new scale – here the
French AMS – to provide evidence that reliability or repli-
cability is sufficiently good and not different from the
same scale in other language regions. We used only the
Cronbach's alpha measure. In contrast to systematic and
random variation, reliability gives an estimate of method-
related measurement error that should be low – what
translates in a high consistency coefficient "alpha".
A second basic requirement is validity: whereas reliability
can be determined easily with a relatively simple indica-
tor, the validity is almost always a continuous process
(construct validation). As a first step, we will analyse the
internal structure of the French AMS and analyze the total
scale and sub-scales by means of factorial analysis. If the
scale is similar to the scales used in other countries in
Europe (particularly in Germany), the same domains
should be identified and similar factor loadings should be
found.
The analyses were done with SPSS Windows 10.0 and
STATA 6.0.
Results and Discussion
Reliability
Table 1 shows the internal consistency measured with
Cronbach's Alpha. The consistency coefficients "alpha"
fell between 0.7 and 0.9 in France. The values are not
materially different from the alpha values in the com-
bined European sample, i.e. for the AMS total score as well
the three subscales. This is indicative for a very acceptable
consistency of the French AMS scale – and – compatible
with Europe outside France.
In addition, the very close mean values (SD) of the scale's
total score and domain scores in the two comparison
groups contribute to evidence that the scale does not work
differently in France compared to the rest of Europe.
Test-retest correlation coefficients (Pearson's correlation)
in a very small sample in France were earlier published [6]
and support the above conclusion: Cronbach's alpha for
total scale and domains ranged from 0.7 to 0.9 (details in
[6]).Health and Quality of Life Outcomes 2005, 3:20 http://www.hqlo.com/content/3/1/20
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Validity
The first step of validation is usually to multivariately
demonstrate the internal structure ("dimensions") of a
given scale through factor analysis.
Table 2 shows the comparison of the factorial structure of
the French AMS scale and "Europe, others". The structure
of the French AMS is not materially different from
"Europe, others", i.e. the same three domains were found
in the French scale as were described initially for the Ger-
man original scale. In addition, the proportion of
explained variance by the AMS scale is also very similar:
52% and 56% in the French and European analysis (52%
in the original German scale in 1999). The loadings of the
17 items on the 3 factors/domains of the French AMS are
astonishingly similar with those from rest of "Europe,
others".
Thus, the French scale does obviously not differ from
other versions, and particular the German original, i.e.
from this perspective.
However, as reported in a previous publication [6], there
are two items that are not particularly helpful in forming
the sexual factor: The statement that the beard growth
decreased and the feeling to have "passed the peak of life".
The loading were (very) low, or showed up in two
different domains. Thus, also the French AMS supports
the conclusion of an earlier publication [6], " that item 12
....14 could be eliminated if a new standardization is
Table 1: Internal consistency coefficients (alpha) for the AMS scale in France compared with rest of Europe: total score and scores for 
the psychological, somatic, and sexual sub-scale. Mean and SD of the scale and sub-scales. Community samples.
France (N= 903) Europe* (N = 5907)
Mean (SD) alpha Mean (SD) alpha
Total score 27.7 (9.3) 0.89 28.0 (9.4) 0.90
Psychological score 7.6 (2.9) 0.75 7.4 (3.1) 0.82
Somatic score 12.5 (4.7) 0.81 12.6 (4.7) 0.81
Sexual score 7.6 (3.1) 0.76 7.9 (3.4) 0.80
* Database is identical with the methodological review of international data published earlier [6] and kindly provided by L.A. J. Heinemann
Table 2: Internal structure and domains of the AMS scale. Comparison of community samples of France and other countries of Europe 
[6]
N FRANCE 903 EUROPE, other 5907
Item Nr. Psych Somat Sex Psych Somat Sex
Burned out 13 0.3 0.6 0.7
Depressive, more 11 0.5 0.6 0.8
Irritability, increased 6 0.7 0.6
Anxious, more 8 0.6 0.7
Nervousness, more 7 0.7 0.6
Joint complaints, more 2 0.6 0.7
Sweating, increased 3 0.5 0.4 0.5
Sleep, need for more 5 0.7 0.6
Well-being, impaired 1 0.7 0.7
Sleep disturbances, more 4 0.6 0.6
Muscular weakness 10 0.6 0.6
Physical exhaustion 9 0.6 0.6
Sexual potency, impaired 15 0.8 0.9
Morning erections, less 16 0.8 0.9
Libido, disturbed 17 0.8 0.8
Passed peak 12 0.5 0.5 0.4
Decrease of beard growth 14 0.2 0.4 0.3
Factor loadings only depicted if 0.5 or more# in the sub-scales: psychological (psych), somatic (somat), and sexual sub-scale (sex). # Except if 
conflicting loadings /not in original domain (italic)Health and Quality of Life Outcomes 2005, 3:20 http://www.hqlo.com/content/3/1/20
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planned". This however seems not to be feasible in the
near future.
Three other items from the psychological domain (burned
out, depressive, sweating) have low loadings on more
than one domain (somatic domain) in the French AMS or
even slightly higher loadings in the "wrong domain".
Nevertheless, similarity with the original German AMS
scale [6] and "Europe, others" is dominating some differ-
ences (including those mentioned above). At least, this
seems not to undermine the quality of the French AMS
scale. Moreover, it is not likely that these weaknesses
influence the use of the scale in practice since individual
items are not used – only average scores of the total scale
or the three domains. Moreover, it is unlikely to have neg-
ative impact on multinational studies, because intra-indi-
vidual comparisons over time (before/after treatment) are
the main criterion that might not be affected very much.
Sub-scores and total score correlations
The relations among the sub-scales and the aggregate total
scale are patterns that are important in the methodologi-
cal assessment of a scale. In theory, the correlations
between subscales (supposed to be independent) should
Table 3: Internal structure and domains of the AMS scale. Comparison of community samples of France and other countries of Europe 
[6] in 2 age groups.
N France 903 Europe, other 5907
Age Under = 50 (n = 617)* Over 50 (n = 346) Under = 50 (n = 459)* Over 50 (5448)
Item Nr. Psych Somat Sex Psych Somat Sex Psych Somat Sex Psych Somat Sex
Burned out 13 0.2 0.6 0.4 0.6 0.7 0.7
Depressive, more 11 0.6 0.7 0.5 0.5 0.8
Irritability, increased 6 0.6 0.6 0.6 0.6
Anxious, more 8 0.6 0.7 0.7 0.7
Nervousness, more 7 0.7 0.7 0.7 0.7
Joint complaints, more 2 0.6 0.6 0.7 0.8
Sweating, increased 3 0.6 0.2 0.4 0.2 0.6 0.5
Sleep, need for more 5 0.7 0.7 0.6 0.6
Well-being, impaired 1 0.7 0.6 0.6 0.7
Sleep disturbances, more 4 0.6 0.6 0.6 0.5
Muscular weakness 10 0.6 0.7 0.5 0.5 0.6
Physical exhaustion 9 0.7 0.6 0.6 0.6
Sexual potency, impaired 15 0.7 0.8 0.9 0.9
Morning erections, less 16 0.7 0.8 0.8 0.9
Libido, disturbed 17 0.7 0.8 0.8 0.8
Passed peak 12 0.5 0.3 0.4 0.4 0.3 0.6 0.4 0.1 0.5 0.4
Decrease of beard growth 14 0.4 0.4 0.7 0.3 0.4 0.3
Factor loadings only depicted if 0.5 or more# in the sub-scales: psychological (psych), somatic (somat), and sexual sub-scale (sex).
#Except if conflicting loadings /not in original domain (italic).
*Age range different: France 15–50, Europe 40–50
Table 4: Domain score – total score correlations of the AMS scale. Comparison between French and other European community 
samples.
DOMAINS
Psychological score Somatic score Sexual score
France (n = 903)
Total score 0.8 0.9 0.8
Psychological score -- 0.7 0.5
Somatic score -- -- 0.6
Other Europe (n = 5907)
Total score 0.8 0.9 0.8
Psychological score -- 0.7 0.5
Somatic score -- -- 0.5Health and Quality of Life Outcomes 2005, 3:20 http://www.hqlo.com/content/3/1/20
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be much lower than the correlations with the total score
to which all sub-scales should significantly contribute –
the domains are really independent from each other (as
suggested by the factorial analysis with orthogonal fac-
tors). However, table 4 shows only a somewhat lower
Pearson's correlation among sub-scales (r = 0.5–0.7) as
compared with correlation of sub-scales with the total
score (r = 0.8–0.9).
This suggests that the sub-scales are not as independent
from each other as one would expect them to be according
to the applied model. However, this is again identical for
the French AMS and the results obtained in "Europe, oth-
ers". This however means, that the results of subscales
should no be seen in isolation but in the context of other
scales, or the result of the total score.
French AMS and other scales
A sufficient correlation with an internationally well-
accepted QoL scale, like SF 12 [7], should be demon-
strated also for the French AMS – to check the claim that
the AMS scale is a health-related QoL scale.
We applied both scales to all participants of the second
half of the French survey (n = 461).
High Pearson's correlation coefficients were observed
between the total AMS score and the subscale PCS-12 (r =
0.48; p < 0.0001) as well as with MSC-12 or the SF-12 (r =
0.51; p < 0.0001). For comparison, other authors [3]
reported as concurrent validity high correlations of the
German AMS scale with the SF-36 for an older population
sample (40–70 years): Similar to our results with SF-12,
the AMS total score was statistically significant correlated
with SF-36: r = 0.49 (p < 0.0001).
Similarly, we observed a good Pearson's correlation with
the HAD depression scale [8] and the AMS total score (r =
0.62; p < 0.0001).
We conclude that the French AMS is as able to measure
HRQoL as observed for the German version. In addition
the AMS result can reflect the degree of depression as
measured with the HAD scale.
AMS applicable for all age groups
The utility of the AMS scale for younger age groups is
another question that was often raised but not answered
yet due to lack of data. The representative French study
included also younger age groups (from 15 years
upward). Table 3 (see Additional file) shows the dimen-
sions/domains of the French and the "Europe, others"
results in two broad age groups (under/equal 50 vs. over
50 years). The factor loadings of the three domains differ
not systematically between the two age groups. It should
be kept in mind that the French sample included males
from 15 years upward whereas the sample "Europe, oth-
ers" started with 40 years.
To answer the question if the AMS measures different phe-
nomena in groups under 40 than in "aging males" over
40, we further stratified the French sample and repeated
the factor analysis for 10-year age groups (Table 5 [see
Additional file]): There is clear evidence from this analysis
that the AMS scale measures a similar phenomenon
(HRQoL) in all age groups. Of course, the proportion of
persons with impaired HRQoL increases with age, i.e. the
mean total and domain scores of the AMS increases with
10-year age groups. The mean values of the AMS total
score were in the French study: 24.6, 24.7, 27.3, 30.3, and
32.4 scoring points for the age groups under 30, 30–39,
40–49, 50–59, and 60+ years old, respectively. Similarly,
the mean scoring points of the three domains increase
with age – particularly so in the psychological and somatic
domain (data not shown).
Table 5 (see Additional file) shows a tendency that the
scale explains an increasing percentage of the total vari-
ance with increasing age, although the numbers are in the
same ballpark (ranging from 46% to 56%). The factor
loading in the somatic and sexual domain seems to be
quite stable across age groups. The psychological domain
seems to vary more but not clearly associated with
increasing age. As discussed above, some items of the scale
are more unstable in their association to only one factor
and have low loadings in the French study: item 12 and 14
of the sexual domain ("passed peak", beard growth"),
item 11 and 13 of the psychological domain ("depressive,
"burned out"), and item 3 of somatic domain ("sweat-
ing"). In general, the internal structure of the scale is
remarkably similar across age groups.
From this result we suggest that the name of the Aging
Males' Symptoms scale might be somewhat misleading:
The AMS could be applicable in all age groups to measure
HRQoL and not only in "aging males", if the results of the
French study can be confirmed in other studies.
Thus, we could also calculate reference values across age
with the French survey. This will be published in a joint
review paper together with reference values from other
countries than Germany that became available in recent
time. This paper is under preparation.
Conclusion
The French AMS scale is a standardized HRQoL scale with
good psychometric characteristics (reliability, validity) as
shown for other international versions. We suggest that
the AMS scale should be also used in age groups under 40
to measure and compare HRQoL in males. Since theHealth and Quality of Life Outcomes 2005, 3:20 http://www.hqlo.com/content/3/1/20
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application of the AMS in younger age was not investi-
gated before, confirmation in future studies is needed.
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Table 5: Internal structure and domains of the AMS scale in 10-year age groups. Comparison across age in the French community 
sample (n = 903).
Total scale: % variance 
explained
49.6 46.2 52.5 56.7 52.2
Domains: % variance 
explained
13.5 20.2 15.9 17.6 18.3 10.3 12.2 23.1 17.2 10.3 28.9 17.4 17.7 20.3 14.1
Age group (years) Under 30 (n = 197) 30–39 (n = 203) 40–49 (n = 169) 50–59 (n = 154) 60+ (n = 180)
Item Nr. Psych Somat Sex Psych Somat Sex Psych Somat Sex Psych Somat Sex Psych Somat Sex
Burned out 13 0.2 0.5 0.1 0.6 0.3 0.5 0.2 0.7 0.5 0.5
Depressive, 
more
11 0.6 0.8 0.5 0.5 0.2 0.8 0.6
Irritability, 
increased
6 0.5 0.6 0.7 0.8 0.5
Anxious, 
more
8 0.6 0.7 0.7 0.3 0.6 0.8
Nervousness, 
more
70 . 4 0.6 0.3 0.5 0.3 0.7 0.6 0.7
Joint 
complaints, 
more
2 0.7 0.6 0.5 0.5 0.6
Sweating, 
increased
30 . 5 0.5 0.1 0.6 0.2 0.5 0.6 0.2
Sleep, need 
for more
5 0.6 0.6 0.6 0.8 0.6
Well-being, 
impaired
1 0.6 0.5 0.6 0.8 0.8
Sleep 
disturbances, 
more
40 . 6 0.4 0.4 0.6 0.6 0.5
Muscular 
weakness
10 0.6 0.5 0.5 0.6 0.7
Physical 
exhaustion
9 0.6 0.6 0.6 0.6 0.6
Sexual 
potency, 
impaired
15 0.8 0.6 0.2 0.8 0.7 0.8
Morning 
erections, 
less
16 0.7 0.6 0.3 0.7 0.8 0.8
Libido, 
disturbed
17 0.7 0.5 0.7 0.8 0.8
Passed peak 12 0.7 0.2 0.5 0.4 0.5 0.4 0.3 0.3 0.4 0.4
Decrease of 
beard growth
14 0.7 0.8 0.7 0.7 0.2 0.5 0.4
Factor loadings only depicted if 0.5 or more# in the sub-scales: psychological (psych), somatic (somat), and sexual sub-scale (sex).
# Except if conflicting loadings /not loading in the original domain (italic)Publish with BioMed Central    and   every 
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